Summary
Updated Aug 31, 2026
Raymond Debbane is Director of LEXICON PHARMACEUTICALS, INC. (LXRX). 8 SEC Form 4 filings on record going back to 2025, most recently on 4 June 2026. Most recent open-market trade: bought $3K of LXRX on 27 February 2026. Lifetime open-market purchases: $723K. Historical track record: 5/5 stars across 7 tracked purchases.
Recent Transactions
9Every recent SEC Form 4 transaction Raymond Debbane has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 7 |
| Purchases with forward-return data | 7 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +5.18% |
| Avg 30-day return | +14.93% |
| Avg 90-day return | +53.17% |
| Best 30-day return | +22.90% |
Trading Pattern
InsiderAlpha's records for Raymond Debbane go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $103K (7 buys totaling $723K). The largest single buy on record is $176K of LXRX in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Raymond Debbane files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Invus Global Management, LLC - $2.00M of LXRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Raymond Debbane?
Raymond Debbane is a corporate insider, tracked as Director of LEXICON PHARMACEUTICALS, INC. (LXRX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Raymond Debbane submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Raymond Debbane been buying or selling stock?
Recorded transactions: 7 open-market purchases ($723K) and 0 open-market sales across all tracked filings.
How accurate is Raymond Debbane's historical track record?
Across 7 tracked purchases, Raymond Debbane averaged +14.9% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Raymond Debbane's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Raymond Debbane and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial